11.48
-1.54%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Shenzhen Lifotronic Technology Co
Its shares trade on Shanghai under the ticker 688389.SS. It has been listed since 5 November 2019. In the fiscal year to 31 December 2025, it reported revenue of CN¥1.04bn and net income of CN¥186.1m. At that date it held total assets of CN¥2.81bn and shareholders' equity of CN¥2.12bn.
Shenzhen Lifotronic Technology Co., Ltd. engages in the research and development, and manufacture of medical devices. The company is headquartered in Shenzhen, Guangdong. The company went IPO on 2019-11-05. The firm focuses on the development and technological innovation of treatment and rehabilitation equipment, in vitro diagnostic equipment and supporting detection reagents. The firm's products mainly include wound and skin treatment products, perioperative and intensive care products, pain and rehabilitation treatment products and in vitro diagnostic products. The firm mainly conducts its businesses in domestic and overseas markets.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 5 Nov 2019
- Employees
- 1,375
- Website
- lifotronic.com ↗
Leadership
Pay as last reported
- Mr. Xiancheng LiuChairman of the Board, since 2020CN¥718,900
- Ms. Hong WangChief Financial Officer, Director, since 2023CN¥397,500
- Mr. Minglong HuGeneral Manager, Director, since 2020CN¥628,500
- Mr. Dawei LiDeputy General Manager, Director, since 2020CN¥322,500
- Mr. Ying ZengDeputy General Manager, Director, since 2020CN¥613,100
- Mr. Liang QiuDeputy General ManagerCN¥398,500
- Mr. Guoqing PengResearch and Development DirectorCN¥350,600
- Mr. Zheng WangResearch and Development DirectorCN¥401,400
- Ms. Man LuSecretary of the Board
- Mr. Lei XiangDirectorCN¥366,500
- Mr. Qiaowu CaiIndependent DirectorCN¥80,000
- Mr. Guanghui YangIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Shenzhen Lifotronic Technology employs 1,375 full-time employees for medical device innovation.
- The company focuses on in vitro diagnostic equipment and treatment rehabilitation equipment development.
- Shenzhen Lifotronic Technology has a strong domestic and overseas market presence.
Weaknesses
- The company's business is limited to medical devices without diversification into other sectors.
- Shenzhen Lifotronic Technology has no mention of international expansion beyond current markets.
- The firm's product range lacks mention of new technology integration beyond current offerings.
Opportunities
- The global health care market continues to grow with increasing demand for medical devices.
- Shenzhen Lifotronic Technology can expand its in vitro diagnostic product line internationally.
- The company can leverage its domestic market to enter new overseas markets.
Threats
- Competition in the health care sector intensifies with new entrants and established players.
- Regulatory changes in medical device manufacturing could impact production and sales.
- Economic downturns may reduce healthcare spending and affect demand for medical devices.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.